STAT3 Phosphorylation Mediating DMSO's Function on Fetal Cardiomyocyte Proliferation with Developmental Changes

Notch signaling modulation enhances porcine muscle stem cell proliferation and differentiation

Muscle stem cells (MuSCs) represent a promising starting material for the production of cultured meat. However, MuSCs exhibit impaired proliferative capabilities when cultured at high-density, with the underlying signaling pathways yet to be fully characterized. In this study, we revealed that Notch signaling was activated in response to high-density conditions in porcine MuSCs. Consistently, treatment with DAPT, a specific inhibitor of Notch signaling, significantly improved the proliferation of MuSCs cultivated at high-density. Further, Notch signaling was gradually repressed during MuSC differentiation. Notably, DAPT accelerated this downregulation process, thereby significantly promoting the myogenic differentiation potential of MuSCs. In summary, this study highlights the critical role of Notch signaling in regulating the proliferation and differentiation of MuSCs. Through modulating the activity of Notch signaling, we have identified a strategy to achieve extensive expansion of MuSCs and to enhance their myogenic differentiation.

Fibrinogen-like protein 2 contributes to normal murine cardiomyocyte maturation and heart development

NEW FINDINGS

What is the central question of this study? What is the role of fibrinogen-like protein 2 (FGL2) in murine cardiomyocyte maturation? What is the main finding and its importance? This is the first study showing both global Fgl2 knockout and cardiac-specific FGL2 deletion trigger early death and dilated cardiomyopathy. By using an adeno-associated virus (AAV)-mediated CRISPR/Cas9-based somatic mutagenesis system, it was demonstrated that cardiac-specific FGL2 depletion induces ventricular dilatation and remodelling, and disrupts the normal hypertrophic growth and polyploidization of cardiomyocytes. In addition, it was shown that modulation of signal transducer and activator of transcription 3, extracellular signal-regulated kinases 1 and 2 and fibroblast growth factor 2 signalling is associated with loss-of-FGL2-mediated cardiac dysfunction. These results suggest FGL2 is an important determinant of cardiomyocyte maturation.

ABSTRACT

In the first few weeks after birth in altricial mammals, postnatal cardiomyocytes (CMs) undergo dramatic changes, including cell volume enlargement, cell cycle withdrawal and polyploidization to become mature CMs. Aberrations in this process could disrupt the essential contractility and synchronization of adult CMs, leading to various heart diseases. However, the mechanism of CM maturation is poorly understood. Fibrinogen-like protein 2 (FGL2) is an immune coagulant which participates in maturation of multiple cell types. However, little evidence exists regarding a role of FGL2 in CM maturation. In this study, we observed that global Fgl2^-/- pups had high lethality and suffered from cardiac dysfunction before P28. To further confirm the phenotype and study the mechanisms upon FGL2 deficiency, we used an adeno-associated virus (AAV)-mediated CRISPR/Cas9-based somatic mutagenesis system to generate loss-of-function mutations of Fgl2 specifically in CMs. We designed two guide RNAs (gRNAs) exclusively targeting Fgl2 exon1 and produced Fgl2-gRNA AAV9 to deliver to neonatal Cas9 mice. Here, we demonstrated the efficient FGL2 depletion in the heart after Fgl2-gRNA AAV9 delivery. Consistent with the findings in global Fgl2^-/- mice, we observed AAV9-mediated FGL2 depletion triggered early death and dilated cardiomyopathy. In addition, FGL2 depletion perturbed the normal hypertrophic growth and polyploidization of maturing CMs. Furthermore, we found modulation of signal transducer and activator of transcription 3, extracellular signal-regulated kinases 1 and 2 and fibroblast growth factor 2 signalling was associated with FGL2 deficiency-mediated cardiac dysfunction. Here, we demonstrate the successful depletion of FGL2 in maturing CMs in vivo and show FGL2 is an important determinant for normal CM maturation.

Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models

Targetable alterations in cancer offer novel opportunities to the drug discovery process. However, pre-clinical testing often requires solubilization of these drugs in cosolvents like dimethyl sulfoxide (DMSO). Using a panel of cell lines commonly used for in vitro drug screening and pre-clinical testing, we explored the DMSO off-target effects on functional signaling networks, drug targets, and downstream substrates. Eight Non-Small Cell Lung Cancer (NSCLC) cell lines were incubated with three concentrations of DMSO (0.0008%, 0.002%, and 0.004% v/v) over time. Expression and activation levels of 187 proteins, of which 137 were kinases and downstream substrates, were captured using the Reverse Phase Protein Array (RPPA). The DMSO effect was heterogeneous across cell lines and varied based on concentration, exposure time, and cell line. Of the 187 proteins measured, all were statistically different in at least one comparison at the highest DMSO concentration, followed by 99.5% and 98.9% at lower concentrations. Only 46% of the proteins were found to be statistically different in more than 5 cell lines, indicating heterogeneous response across models. These cell line specific alterations modulate response to in vitro drug screening. Ultra-low DMSO concentrations have broad and heterogeneous effects on targetable signaling proteins. Off-target effects need to be carefully evaluated in pre-clinical drug screening and testing.